Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2014 07:00 ET | Source: REGENXBIO Inc.

REGENX Biosciences and Voyager Therapeutics Announce License Agreement

Voyager acquires rights to REGENX's proprietary NAV® vectors in multiple CNS disorders Eighth third-party commercial license of REGENX's NAV vectors since 2010 REGENX to receive undisclosed...